We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovision Res. | LSE:INN | London | Ordinary Share | GB0030308448 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.75 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMINN RNS Number : 0140O Innovision Research&Technology PLC 22 June 2010 FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code") 1. KEY INFORMATION +-----------------+------------+ | (a) | Innovision | | Identity | Research | | of the | and | | party to | Technology | | the | plc | | offer | | | making | | | the | | | disclosure: | | +-----------------+------------+ | (b) | N/A | | Owner | | | or | | | controller | | | of | | | interests | | | and short | | | positions | | | disclosed, | | | if | | | different | | | from 1(a): | | | The | | | naming of | | | nominee or | | | vehicle | | | companies | | | is | | | insufficient | | +-----------------+------------+ | (c) | OFFEREE: | | Name | Innovision | | of | Research | | offeror/offeree | and | | in relation to | Technology | | whose relevant | plc | | securities this | | | form relates: | | | Use a | | | separate form | | | for each party | | | to the offer | | +-----------------+------------+ | (d) Is | OFFEREE | | the | | | party | | | to the | | | offer | | | making | | | the | | | disclosure | | | the | | | offeror or | | | the | | | offeree? | | +-----------------+------------+ | (e) | 22/06/2010 | | Date | | | position | | | held: | | +-----------------+------------+ | (f) | NO | | Has | | | the | | | party | | | previously | | | disclosed, | | | or is it | | | today | | | disclosing, | | | under the | | | Code in | | | respect of | | | any other | | | party to | | | this offer? | | +-----------------+------------+ 2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates +----------------+--------+--------+--------+--------+ | Class | | | of | | | relevant | | | security: | | | | | +----------------+-----------------------------------+ | | Interests |Short positions | | | | | + +-----------------+-----------------+ | |Number | % |Number | % | +----------------+--------+--------+--------+--------+ | (1) | | | | | | Relevant | | | | | | securities | | | | | | owned | | | | | | and/or | | | | | | controlled: | | | | | +----------------+--------+--------+--------+--------+ | (2) | | | | | | Derivatives | | | | | | (other than | | | | | | options): | | | | | +----------------+--------+--------+--------+--------+ | (3) | | | | | | Options | | | | | | and | | | | | | agreements | | | | | | to | | | | | | purchase/sell: | | | | | +----------------+--------+--------+--------+--------+ | | | | | | | | | | | | | TOTAL: | | | | | +----------------+--------+--------+--------+--------+ All interests and all short positions should be disclosed. Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL). (b) Rights to subscribe for new securities +--------------+--------+ | Class | nil | | of | | | relevant | | | security | | | in | | | relation | | | to which | | | subscription | | | right | | | exists: | | +--------------+--------+ | Details, | nil | | including | | | nature of | | | the | | | rights | | | concerned | | | and | | | relevant | | | percentages: | | +--------------+--------+ If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (c) Irrevocable commitments and letters of intent +-------------+ | Details | | of any | | irrevocable | | commitments | | or letters | | of intent | | procured by | | the party | | to the | | offer | | making the | | disclosure | | or any | | person | | acting in | | concert | | with it | | (see Note 3 | | on Rule | | 2.11 of the | | Code): | +-------------+ | | | None | | | +-------------+ 3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE +----------------+ | Details | | of any | | interests, | | short | | positions | | and rights | | to | | subscribe | | of any | | person | | acting in | | concert | | with the | | party to | | the offer | | making the | | disclosure: | +----------------+ | | | The | | Directors | | of the | | Company | | hold the | | following | | interests | | and | | rights to | | subscribe: | | Malcolm | | Baggott | | (Chairman) | | 79,934 | | Ordinary | | 1p shares | | (representing | | approximately | | 0.087% of the | | issued share | | capital of | | Innovision | | Research and | | Technology | | plc) | | David Wollen | | (Chief | | Executive) | | 74,933 | | Ordinary 1p | | shares | | (representing | | approximately | | 0.082% of the | | issued share | | capital of | | Innovision | | Research and | | Technology | | plc) | | 573,770 | | options over | | Ordinary | | shares of 1p | | each. The | | exercise | | price of each | | option is | | GBP0.61. The | | options are | | exercisable | | until 7 | | February | | 2016. | | 300,000 | | options over | | Ordinary | | shares of 1p | | each. The | | exercise | | price of each | | option is | | GBP0.01. The | | options are | | exercisable | | until 19 July | | 2016. | | 1,000,000 | | options over | | Ordinary | | shares of 1p | | each. The | | exercise | | price of each | | option is | | GBP0.1175. | | The options | | are | | exercisable | | between 5 | | August 2011 | | and 5 August | | 2018. | | 750,000 | | options over | | Ordinary | | shares of 1p | | each. The | | exercise | | price of each | | option is | | GBP0.185. | | The options | | are | | exercisable | | between 21 | | January 2013 | | and 21 | | January 2020. | | Brian | | McKenzie | | (Chief | | Financial | | Officer) | | 41,600 | | Ordinary 1p | | shares | | (representing | | approximately | | 0.045% of the | | issued share | | capital of | | Innovision | | Research and | | Technology | | plc). | | 500,000 | | options over | | Ordinary | | shares of 1p | | each. The | | exercise | | price of each | | option is | | GBP0.1175. | | The options | | are | | exercisable | | between 5 | | August 2011 | | and 5 August | | 2018. | | 250,000 | | options over | | Ordinary | | shares of 1p | | each. The | | exercise | | price of each | | option is | | GBP0.185. | | The options | | are | | exercisable | | between 21 | | January 2013 | | and 21 | | January | | 2020. | | Steve Morris | | (Chief | | technical | | Officer) | | 5,500 | | Ordinary 1p | | shares | | (representing | | approximately | | 0.006% of the | | issued share | | capital of | | Innovision | | Research and | | Technology | | plc) | | 500,000 | | options over | | Ordinary | | shares of 1p | | each. The | | exercise | | price of each | | option is | | GBP0.1175. | | The options | | are | | exercisable | | between 20 | | January 2012 | | and 20 | | January 2019. | | Ian | | Buckley-Golder | | (Senior | | Independent | | Non-executive | | Director) | | 72,350 | | Ordinary 1p | | shares | | (representing | | approximately | | 0.079% of the | | issued share | | capital of | | Innovision | | Research and | | Technology | | plc) | | | +----------------+ If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security. Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL). 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements +-----------------+ | Details | | of any | | indemnity | | or option | | arrangement, | | or any | | agreement or | | understanding, | | formal or | | informal, | | relating to | | relevant | | securities | | which may be | | an inducement | | to deal or | | refrain from | | dealing | | entered into | | by the party | | to the offer | | making the | | disclosure or | | any person | | acting in | | concert with | | it: | | If there are | | no such | | agreements, | | arrangements | | or | | understandings, | | state "none" | +-----------------+ | | | NONE | | | +-----------------+ (b) Agreements, arrangements or understandings relating to options or derivatives +-----------------+ | Details | | of any | | agreement, | | arrangement | | or | | understanding, | | formal or | | informal, | | between the | | party to the | | offer making | | the | | disclosure, or | | any person | | acting in | | concert with | | it, and any | | other person | | relating to: | | (i) the | | voting rights | | of any | | relevant | | securities | | under any | | option; or | | (ii) the | | voting rights | | or future | | acquisition or | | disposal of | | any relevant | | securities to | | which any | | derivative is | | referenced: | | If there are | | no such | | agreements, | | arrangements | | or | | understandings, | | state "none" | +-----------------+ | | | NONE | | | +-----------------+ (c) Attachments Are any Supplemental Forms attached? +--------------+--------+ | Supplemental | NO | | Form 8 (Open | | | Positions) | | +--------------+--------+ | Supplemental | NO | | Form 8 (SBL) | | +--------------+--------+ +-------------+-------------+ | Date | 22 | | of | June | | disclosure: | 2010 | +-------------+-------------+ | Contact | Brian | | name: | McKenzie | +-------------+-------------+ | Telephone | +44 | | number: | (0) | | | 1285 888200 | +-------------+-------------+ Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk. This information is provided by RNS The company news service from the London Stock Exchange END FEEPGUAPQUPUUBP
1 Year Innovision Research&technology Chart |
1 Month Innovision Research&technology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions